Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YDR2 | ISIN: US5845071076 | Ticker-Symbol: N/A
1-Jahres-Chart
MEDICAL CARE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
MEDICAL CARE TECHNOLOGIES INC 5-Tage-Chart
ACCESS Newswire
428 Leser
Artikel bewerten:
(2)

Medical Care Technologies Inc. Highlights Melanoma Detection App Development, AI Lifestyle App Launch, and Subsidiary Momentum

MESA, ARIZONA / ACCESS Newswire / January 28, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a developer of innovative healthcare, lifestyle, and technology-driven solutions, today provided a comprehensive update to shareholders outlining significant progress across its core initiatives and subsidiaries.

MDCE is actively developing a mobile application designed to assist in the early detection of melanoma through advanced image analysis and artificial intelligence. Melanoma is one of the most aggressive and deadly forms of skin cancer, with over 300,000 new cases diagnosed globally each year and more than 100,000 cases annually in the United States alone. The global skin cancer diagnostics market is estimated to exceed $10 billion, with AI-powered diagnostic tools representing one of the fastest-growing segments due to rising incidence rates, demand for early detection, and increased accessibility via mobile technology. MDCE believes its melanoma detection initiative represents a meaningful opportunity to address a major public health concern while targeting a substantial and scalable market.

In parallel, the Company is finalizing the Android build of its first AI-based lifestyle application. This inaugural app represents Phase One of MDCE's broader strategy to deploy a diverse catalog of AI-powered mobile applications across lifestyle, general wellness, and medical pre-screening categories. The official name and public launch of the lifestyle app are expected to be announced in the coming weeks.

MDCE subsidiaries continue to demonstrate strong operational momentum:

Infinite Auctions LLC (www.infiniteauctions.com) is preparing for its first fine art auction, having already secured over $1 million in consigned original artwork, with additional high-value acquisitions underway. The subsidiary continues to target assets with significant upside potential, particularly items that may benefit from authentication services provided by MDCE's other subsidiary, Real Game Used.

Real Game Used (RGU) (www.realgameused.com) remains a premier authenticator serving some of the world's most prominent sports collectors and investment-grade memorabilia portfolios. RGU also continues its role as a trusted authentication partner for leading entertainment auction houses, including Gotta Have Rock and Roll, and Backstage Auctions, further expanding its influence beyond traditional sports collectibles.

MDCE believes the combined progress across its healthcare technology initiatives and revenue-generating subsidiaries positions the Company for meaningful growth as it advances its multi-vertical AI strategy.

About Medical Care Technologies Inc. (OTC PINK: MDCE)

Medical Care Technologies Inc. is a technology-focused company developing AI-driven applications across healthcare, lifestyle, wellness, and authentication markets. Through its wholly owned subsidiaries, including Real Game Used and Infinite Auctions, MDCE operates at the intersection of artificial intelligence, consumer applications, and high-value collectibles, with a focus on scalable innovation and long-term shareholder value.
www.medicalcaretechnologies.com

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations, estimates, and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Forward-looking statements include, but are not limited to, statements regarding product development, market opportunity, potential revenues, and future launches. Medical Care Technologies Inc. undertakes no obligation to update or revise these statements except as required by law.

Media & Investor Inquiries

Medical Care Technologies Inc. (OTC PINK:MDCE)
www.medicalcaretechnologies.com
Email: info@infiniteauctions.com

Subsidiaries:
Real Game Used (RGU): www.realgameused.com
Infinite Auctions: www.infiniteauctions.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medical-care-technologies-inc.-otc-pink-mdce-highlights-melanoma-dete-1131150

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.